LGALS1 and depressive symptom measurement: To explain this switch in the action of Gal (1–15) from causing depression and anxiety to enhancing the antidepressant effects of a 5-HT1AR agonist and the SSRI fluoxetine, the existence of GalR1-GalR2-5-HT1AR complexes was proposed.